Dr. Anna H. Zezon, MD

Dr. Zezon practices at Anna Zezon MD in Teaneck, New Jersey.

Dr. Zezon's NPI, 1871866632, was assigned on February 9, 2012. Dr. Zezon holds New Jersey license 25MA10094900.

Dr. Zezon's primary practice is Anna Zezon MD, at 197 Cedar Ln Suite 2 Suite 2, Teaneck, NJ 07666-4300. The practice phone is (201) 975-2400.

Dr. Zezon's primary practice is Anna Zezon MD in Teaneck, New Jersey. Dr. Zezon is also affiliated with Holy Name Medical Center. The medical group on file is Medical Associates at Englewood. Dmand AI also links Dr. Zezon to 1 more hospital, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zezon practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Zezon's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Zezon's licenses on file in 2 states: New Jersey and New York.

CMS data shows 4,888 Medicare services from Dr. Zezon across 12 procedure codes in 2024, for 166 Medicare patients. Medicare paid $169,070 for them. Every service was in an office.

CMS counts 166 Medicare patients who saw Dr. Zezon in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zezon's median patient age at 55, with 77% women.

In 2024, Dr. Zezon wrote 536 Medicare Part D claims for 109 patients. 75% of them were for generic drugs. CMS names the drug for 362 of them, across 9 drugs with 11 or more claims each, at $503,524 in total drug cost. In 2023, CMS named 360 claims across 9 drugs.

Dr. Zezon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zezon as offering telehealth.

Dmand AI links 3 papers to Dr. Zezon, published from 2012 to 2020. 2012 was the busiest year, with 2. Dr. Zezon's most frequent co-authors are Saakshi Khattri, MD, Anca D. Askanase, MD and Howard M. Belmont, MD.

CMS Open Payments shows 467 general payments to Dr. Zezon from 36 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 96% of the total. Amgen Inc. paid the most, $1,442.